Kenneth S. Koblan

Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

Nancy E. Kohl, Charles A. Omer, Michael W. Conner et al. · Nature Medicine · 1995 · 538 citations

Farnesyltransferase Induces Regression, Tumor Biology, Chemoprevention Strategy +12

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

Kenneth S. Koblan, Justine Kent, Seth C. Hopkins et al. · New England Journal of Medicine · 2020 · 278 citations

Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases

H Wang, Hu Sun, Kimberly Della Penna et al. · Neuroscience · 2002 · 253 citations

Neurodegenerative Diseases, Pain Syndrome, Chronic Neuropathic Pain +11

Receptor Activity-modifying Protein 1 Determines the Species Selectivity of Non-peptide CGRP Receptor Antagonists

John Mallee, Christopher Salvatore, Beatrice LeBourdellès et al. · Journal of Biological Chemistry · 2002 · 190 citations · Full text

A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis

Rebecca E. Barrington, Mark A. Subler, Elaine Rands et al. · Molecular and Cellular Biology · 1998 · 172 citations · Full text

Ras/myc Tumors, Farnesyltransferase Inhibitor L-744,832, Chemoprevention Strategy +14